PhenomeX Q2 Adj EPS $(0.33) Misses $(0.32) Estimate, Sales $14.06M Miss $17.35M Estimate
Portfolio Pulse from sunil@benzinga.com
PhenomeX (NASDAQ:CELL) reported Q2 losses of $(0.33) per share, missing the analyst consensus estimate of $(0.32) by 3.13%. The company also reported quarterly sales of $14.06M, missing the estimate of $17.35M by 18.95%. This represents a 13.16% increase in losses and a 26.57% decrease in sales compared to the same period last year.
August 14, 2023 | 8:38 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
PhenomeX's Q2 results missed estimates, with increased losses and decreased sales compared to last year.
PhenomeX's Q2 results missed both EPS and sales estimates, which could negatively impact investor sentiment and lead to a decrease in the company's stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100